Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates
 HQ Team July 22, 2025: Sanofi SA will acquire UK-based Vicebio Ltd. for $1.6 billion to gain access to vaccine candidates for respiratory.
Drugs
Health
Pharma